Specialized Clinical Expertise IDDI's extensive experience in advanced biostatistics and complex clinical study design positions it as a go-to partner for pharmaceutical, biotechnology, and medical device companies seeking customized regulatory and data management solutions.

Strong Market Presence With a revenue range of 10 to 50 million and over 50 employees, IDDI demonstrates a substantial footprint in the clinical research space, offering opportunities to expand its client base among mid-sized to large biotech and pharma firms.

Recent Leadership Expansion The appointment of new executive leadership such as Jeremy Edwards as Chief Commercial Officer and Linda Danielson as CEO suggests strategic growth initiatives, making the company more attractive for partnership and outsourcing opportunities.

Innovative Technology Offerings IDDI’s integration of eCRF design services and recent collaborations with RTSM providers like Clario highlight its ability to leverage technology for streamlining clinical trials, which can be a key selling point for clients looking for tech-enabled data solutions.

Growth in Client Engagements Recent client wins and service launches, such as the successful onboarding of Clario RTSM and new resource offerings, indicate the company's active pursuit of new projects and collaborations that can be expanded through targeted outreach.